Analysts expect cbdMD, Inc. to report revenue of 5.31 M for Q4 26, against a range of 5.09 M to 5.53 M. The most recent reported quarter, Q3 26, came in at 5.55 M, a 7.2% miss against the 5.98 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 4.56 M | 5.11 M | 4.75 M | 4.61 M | 4.72 M | 5.02 M | 5.64 M | 5.55 M | - | - | - | - | - | - | - | - | |
| High Estimate | 5.49 M | 5.14 M | 5.15 M | 6.00 M | 5.32 M | 4.91 M | 5.92 M | 6.30 M | 5.53 M | 5.81 M | 6.60 M | 5.90 M | 6.89 M | 6.42 M | 6.89 M | 6.72 M | |
| Low Estimate | 4.51 M | 4.68 M | 4.77 M | 4.96 M | 4.72 M | 4.35 M | 4.90 M | 5.66 M | 5.09 M | 4.93 M | 5.47 M | 5.17 M | 6.02 M | 5.50 M | 6.31 M | 5.56 M | |
| Consensus Estimate | 5.00 M | 4.91 M | 4.96 M | 5.48 M | 5.02 M | 4.63 M | 5.41 M | 5.98 M | 5.31 M | 5.37 M | 6.04 M | 5.54 M | 6.46 M | 5.96 M | 6.60 M | 6.14 M |
Analysts expect cbdMD, Inc. to report earnings per share of -0.09 for Q4 26, against a range of -0.10 to -0.08. The most recent reported quarter, Q3 26, came in at -0.11, a 266.7% miss against the -0.03 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | -1.76 | -1.90 | -0.21 | 2.78 | -0.04 | -0.08 | -0.11 | - | - | - | - | - | - | - | - | |
| High Estimate | -3.24 | -2.51 | -1.50 | -0.02 | -0.07 | -0.06 | -0.05 | -0.03 | -0.08 | -0.09 | -0.08 | -0.09 | 0.52 | 0.03 | 0.49 | 0.40 | |
| Low Estimate | -3.60 | -3.01 | -1.60 | -0.02 | -0.07 | -0.06 | -0.05 | -0.03 | -0.10 | -0.11 | -0.08 | -0.09 | 0.46 | 0.03 | 0.41 | 0.34 | |
| Consensus Estimate | -3.42 | -2.76 | -1.55 | -0.02 | -0.07 | -0.06 | -0.05 | -0.03 | -0.09 | -0.10 | -0.08 | -0.09 | 0.49 | 0.03 | 0.45 | 0.37 |